Several DCEG scientists will present their research at the 2023 International Papillomavirus Conference (IPVC) in Washington, DC and online from April 17-21. The full program can be found on the IPVC website.
Monday, April 17
Chaired Sessions
| Chair | Session | Time |
|---|
| Sarah S. Jackson | Special Interest Satellite Symposium: HPV among transgender and gender diverse individuals: understanding the unique needs of the population | 8:30 - 10:00 AM EDT |
| Aimee R. Kreimer | Public Health Workshop 01: HPV vaccination for prevention of cervical cancer | 1:30 - 3:00 PM EDT |
| Nicolas Wentzensen | Public Health Workshop 02: Cervical Cancer Screening | 2:30 - 5:00 PM EDT |
Oral Presentations
| Presenter | Session | Presentation Title | Time |
|---|
| Julia C. Gage | Special Interest Satellite Symposium: Cervical Cancer Control in Latin America and the Caribbean | A facilitation strategy for rapid, embedded engagement in HPV-based screening implementation planning in low- and middle-income countries (LMICs) | 11:45 AM EDT |
| Megan Clarke | Clinical Workshop 01 | New technologies for screening in developed and developing country settings | 1:30 - 1:50 PM EDT |
| Jaimie Z. Shing | Public Health Workshop 01 | HPV vaccination to prevent invasive cervical cancer | 2:04 - 2:22 PM EDT |
| Anil Chaturvedi | Clinical Workshop 02 | Current epidemiology of head and neck cancer | 3:45 - 4:00 PM EDT |
| Nicolas Wentzensen | Public Health Workshop 02 | Overview of epidemiologic methods: Sensitivity, specificity, predictive value, and risk-based triaging | 4:15 - 4:30 PM EDT |
Tuesday, April 18
Chaired Sessions
| Chair | Session | Time |
|---|
| John T. Schiller | Clinical Workshop 04: New frontier in treatment of HPV-related cancers and pre-cancers | 8:30 - 10:00 AM EDT
|
| Lisa Mirabello | Basic Science Workshop 04: HPV genomics and evolution | 10:30 AM - 12:00 PM EDT
|
Oral Presentations
| Presenter | Session | Presentation Title | Time |
|---|
| Aimee R. Kreimer | Clinical Workshop 03 | HPV vaccine schedules - Latest updates | 9:00 - 9:15 AM EDT |
| Lisa Mirabello | Basic Science Workshop 04 | HPV genetic diversity, APOBEC mutagenesis | 11:30 AM - 12:00 PM EDT |
| John T. Schiller | Clinical Workshop 04 | Can we and should we treat HPV infection? | 11:30 AM - 12:00 PM EDT |
| Meredith Shiels | Public Health Workshop 05 | Evidence of inequity: Incidence and burden of cervical and other HPV-related cancers by ethnicity and race. | 2:00 - 2:15 PM EDT |
| Sarah S. Jackson | Public Health Workshop 05 | HPV vaccination, cancer prevention, and its associated challenges in SGM. | 3:00 - 3:15 PM EDT |
Wednesday, April 19
Panels
| Panelist | Session | Time |
|---|
| Jaimie Z. Shing | Early Career Researchers Session 2: Publish or perish: The future of academic publishing | 7:00 - 8:00 AM EDT |
Chaired Sessions
| Chair | Session | Time |
|---|
| Jaimie Z. Shing | Public Health Oral: Vaccination 1 | 9:45 - 10:45 AM EDT |
| Aimee R. Kreimer | Special Interest Satellite Symposium: Current evidence for safety profile of the HPV Vaccines | 5:15 - 6:45 PM EDT |
Oral Presentation
| Presenter | Session | Presentation Title | Time |
|---|
| Nicolas Wentzensen | Special Interest Satellite Symposium: New guidelines for validation of HPV assays usable in cervical cancer screening | FDA principles for validation of HPV assays in the USA | 10:21 - 10:33 AM EDT |
| Jaimie Z. Shing | Public Health Oral: Vaccination 3 | Differential HPV 16/18 vaccine efficacy against HPV13 by variants in the L1 sequence up to 11-years post-vaccination in the Costa Rica HPV Vaccine Trial | 4:35 - 4:45 PM EDT |
| Nicolas Wentzensen | Clinical Science Oral | Clinical performance of dual stain vs. cytology combined with extended genotyping in a large population of HPV-positive individuals: Implications for cervical cancer screening strategies | 6:35 - 6:45 PM EDT |
Poster Discussion
| Presenter | Session | Presentation Title | Time |
|---|
| Cameron B. Haas | Public Health 02 | Anal test characteristics and disease detection among healthy women referred to high-resolution anoscopy: Findings from the Costa Rica Vaccine Trial Study | 9:15 - 9:20 AM EDT |
Meet the Poster Presenter
| Presenter | Presentation Title | Time |
|---|
| Aimee Koestler | Whole-genome sequencing of 860 HPV45 cases and controls identifies genetic variants specifically associated with cervical glandular lesions | 4:45 - 5:15 PM EDT |
| Summer Harvey | Associations of obesity with cervical cancer screening in the National Health Interview Survey. | 4:45 - 5:15 PM EDT |
| Cameron B. Haas | Anal test characteristics and disease detection among healthy women referred to high-resolution anoscopy: Findings from the Costa Rica Vaccine Trial Study | 5:45 - 5:15 PM EDT |
Thursday, April 20
Chaired Sessions
| Chair | Session | Time |
|---|
| Lisa Mirabello | Clinical Science Oral: Biomarkers for management of cervical lesions with an emphasis on methylation | 10:30 AM - 12:00 PM EDT |
Oral Presentation
| Presenter | Session | Presentation Title | Time |
|---|
| Chase W. Nelson | Basic Science Oral | HPV16 genomics: The untold story of sublineage differences and carcinogenicity | 3:00 - 3:10 PM EDT |
| Lisa Mirabello | Basic Science Oral | HPV16 episomal multimers can form double-minute chromosomal structures and contribute to chromosome rearrangements | 3:30 - 3:40 PM EDT |
| Isabel Rodriguez | Basic Science Oral | A panel of 22 cervical cancer cell lines characterized by long-read DNA and RNA sequencing: Insights into HPV integration and transcription | 3:50 - 4:00 PM EDT |
Poster Discussion
| Presenter | Session | Presentation Title | Time |
|---|
| Erica Stephens | Public Health 03 | Differences in HPV knowledge by race/ethnicity and educational attainment in the United States, Health Information National Trends Survey, 2016-2020 | 2:00 - 2:05 PM EDT |
Friday, April 21
Oral Presentations
| Presenter | Session | Presentation Title | Time |
|---|
| Loretto J. Carvajal | Public Health Oral | Trends in incidence rates of head and neck squamous cell carcinomas in Costa Rica, with a special focus on human papillomavirus-related and-unrelated cancers | 8:50 - 9:00 AM EDT |
| Cameron B. Haas | Public Health Oral | Risk factors for anal high-grade squamous intraepithelial lesions among healthy women: Findings from the Costa Rica HPV Vaccine Trial Study | 9:00 - 9:10 AM EDT |
| Jose A. Jeronimo | Clinical Science Oral | Comparison of accuracy and reproducibility of colposcopic impression based on a single image versus a two-minute time series of colposcopic images | 9:10 - 9:20 AM EDT |
| Camryn M. Cohen | Public Health Oral | Racial and ethnic differences in cervical cancer incidence, survival and mortality by histologic subtype reveal profound disparities | 2:15 - 2:25 PM EDT |
Meet the Poster Presenter
| Presenter | Presentation Title | Time |
|---|
| Jaimie Z. Shing | The incidence of HPV-associated cancers among disaggregated Asian American and Pacific Islander ethnographic regions and ethnicities: A population-based study in the United States | 9:30 - 10:00 AM EDT |
| Jennifer McGee-Avilla | Multilevel determinants of Pap test receipt in women living with HIV: Individual, clinical, and healthcare level patterns of cervical cancer prevention modalities | 9:30 - 10:00 AM EDT |
| Sambit K. Mishra | A longitudinal study of high-risk-HPV genomes reveals intra-host temporal changes to viral single nucleotide variants | 9:30 - 10:00 AM EDT |
| Erica Stephens | Differences in HPV knowledge by race/ethnicity and educational attainment in the United States, Health Information National Trends Survey, 2016-2020 | 9:30 - 10:00 AM EDT |
Keynote Lecture
| Presenter | Presentation Title | Time |
|---|
| Douglas Lowy | The future is now | 4:00 - 5:30 PM EDT |
